{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-247130","form_type":"8-K","ticker":"SRPT","cik":"0000873303","company_name":"Sarepta Therapeutics, Inc.","filed_at":"2022-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.377361+00:00","generated_at":"2026-06-23T08:57:39.370674+00:00","sec_items":["1.01","1.02","2.03","3.02","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Sarepta Therapeutics issues $1.13B in convertible notes, repays $585.5M term loan","bullets":["Issued $1.13B aggregate principal of 1.25% Convertible Senior Notes due 2027 to initial purchasers including Goldman Sachs and J.P. Morgan.","Sold $20M in notes to Michael A. Chambers Living Trust, an affiliate of board member Michael Chambers.","Prepaid $585.5M term loan from BioPharma Credit, including $7M prepayment premium, terminating the Loan Agreement.","Used proceeds to repurchase $150.6M of existing 1.50% Convertible Senior Notes due 2024.","Entered capped call transactions with five counterparties to reduce potential dilution upon conversion of the notes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-247130","json":"https://secwatch.observer/filing/0001193125-22-247130.json","markdown":"https://secwatch.observer/filing/0001193125-22-247130.md","text":"https://secwatch.observer/filing/0001193125-22-247130.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/873303/000119312522247130/0001193125-22-247130-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/873303/000119312522247130/d357082d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T08:57:39.370674+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}